(HealthDay News) — Only 1 in 5 patients with heart failure with reduced ejection fraction (HFrEF) receive digoxin at discharge, according to a study published online in JACC: Heart Failure. Nish Patel ...
Geriatrics and Aging. 2008;11(1):37-41. © 2008 1453987 Ontario, Ltd. Cite this: An Update on the Role of Digoxin in Older Adults with Chronic Heart Failure ...
UB researchers have identified for the first time an enzyme in the foxglove plant that is responsible for the production of compounds needed to make the heart failure drug digoxin. The breakthrough ...
MADRID -- Digitoxin added to guideline-directed medical therapy improved outcomes among patients with heart failure and reduced ejection fraction (HFrEF), the DIGIT-HF trial showed. The cardiac ...
The year saw the emergence of a new version of an old drug that proved beneficial in patients who have heart failure with ...
Heart failure (HF) is the leading cause of hospitalization among older adults. Digoxin has been shown to reduce hospitalization due to worsening HF. However, at the commonly prescribed dose of 0.25 mg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback